Table 2.
Midtreatment assessment | ADC (mm2/s, ×10−3) | D* (mm2/s, ×10−2) | D (mm2/s, ×10−3) | f (mm2/s) | ||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Pre-Tx | Mid-Tx | Pre-Tx | Mid-Tx | Pre-Tx | Mid-Tx | Pre-Tx | Mid-Tx | |
| ||||||||
CR (n = 19) | 0.83 ± 0.17 | 1.7 ± 0.33 | 3.0 ± 1.2 | 3.4 ± 0.12 | 0.69 ± 0.13 | 1.5 ± 0.27 | 0.14 ± 0.05 | 0.25 ± 0.10 |
| ||||||||
Non-CR (n = 40) | 0.94 ± 0.19† | 1.3 ± 0.30 | 3.0 ± 1.4 | 3.5 ± 0.13 | 0.82 ± 0.15† | 1.2 ± 0.29 | 0.13 ± 0.06 | 0.16 ± 0.08 |
| ||||||||
Total (n = 59) | 0.9 ± 0.19 | 1.4 ± 0.35‡ | 3.0 ± 1.3 | 3.5 ± 1.2 | 0.78 ± 0.16 | 1.3 ± 0.31‡ | 0.13 ± 0.05 | 0.19 ± 0.1‡ |
Note.—Tx = treatment, CR = complete response. The data are means with standard deviations.
Significant P = .003 for pre-Tx ADC and D values in the CR group vs. the non-CR.
Significant P < .0001 for mid-Tx ADC, D, and f parameters increase vs. the pre-Tx values.